Fortis Healthcare Sees Sharp Open Interest Surge Amid Weak Price Action

Open Interest and Volume Dynamics

On 12 Aug 2026, Fortis Healthcare’s open interest (OI) surged from 29,664 contracts to 33,978, marking an increase of 4,314 contracts or 14.54%. This rise in OI was accompanied by a total volume of 40,934 contracts traded, indicating heightened activity in the derivatives market. The futures segment alone accounted for a value of approximately ₹19,134.5 lakhs, while options contributed a staggering ₹27,234.3 crores in notional value, culminating in a combined derivatives turnover of ₹23,206.97 lakhs.

The underlying stock closed at ₹890, having opened with a gap down of 5.44% and touched an intraday low of ₹884.3. The weighted average price of traded volumes clustered near the day’s low, suggesting selling pressure dominated throughout the session. Notably, Fortis Healthcare traded within a narrow intraday range of just ₹0.2, reflecting a consolidation phase despite the price drop.

Price Performance and Moving Averages

Fortis Healthcare’s price action has been weak in recent sessions, with the stock falling consecutively for three days, resulting in a cumulative loss of 7.4%. The stock underperformed its Hospital & Healthcare Services sector by 3.28% on the day, while the sector itself declined by 2.36%. Compared to the broader Sensex, which fell by 0.77%, Fortis’s underperformance is pronounced.

Technically, the stock is trading below all key moving averages — 5-day, 20-day, 50-day, 100-day, and 200-day — signalling a bearish trend across multiple timeframes. This technical weakness, combined with falling investor participation as evidenced by an 18.7% drop in delivery volumes to 9.84 lakh shares on 11 Aug, points to cautious sentiment among long-term holders.

Market Positioning and Directional Bets

The simultaneous rise in open interest and decline in price typically indicates that new short positions are being established, or that existing longs are liquidating. In Fortis Healthcare’s case, the 14.5% increase in OI alongside a 5.59% drop in the stock price suggests that bearish bets are gaining traction in the derivatives market.

Volume patterns reinforce this view, with the weighted average price gravitating towards the day’s low, implying that sellers dominated the session. The narrow trading range, however, hints at some indecision or absorption of selling pressure, possibly by institutional participants.

Given Fortis Healthcare’s mid-cap status with a market capitalisation of ₹68,520 crores and a Mojo Score of 60.0, the stock currently holds a 'Hold' rating, upgraded from 'Sell' on 8 Jun 2026. This upgrade reflects a cautious stance amid mixed signals — while the fundamentals and sector outlook remain challenged, the stock’s valuation and recent technical oversold conditions may warrant a wait-and-watch approach.

Sector and Broader Market Context

The Hospital & Healthcare Services sector has been under pressure, declining 2.36% on the day, with Fortis Healthcare underperforming this benchmark. The sector’s weakness is compounded by subdued investor participation, as delivery volumes have fallen significantly, indicating reduced conviction among long-term investors.

In comparison, the Sensex’s modest decline of 0.77% suggests that the broader market is relatively resilient, placing additional spotlight on sector-specific challenges affecting Fortis Healthcare. These include regulatory uncertainties, competitive pressures, and evolving healthcare demand dynamics.

Implications for Investors

Investors should interpret the surge in open interest with caution. The increase in derivatives activity amid falling prices suggests that market participants are positioning for further downside or hedging existing exposures. The stock’s technical weakness across all major moving averages and declining delivery volumes reinforce a cautious outlook.

However, the recent upgrade from 'Sell' to 'Hold' by MarketsMOJO, with a Mojo Score of 60.0, indicates that Fortis Healthcare is not yet a definitive sell. The stock’s liquidity remains adequate, with a daily trade size capacity of approximately ₹4.44 crores based on 2% of the 5-day average traded value, allowing for reasonable entry and exit points.

Given the hospital sector’s ongoing challenges and Fortis’s underperformance relative to peers and the broader market, investors may consider monitoring alternative healthcare stocks or sectors with stronger momentum and fundamentals.

Conclusion

The sharp rise in open interest in Fortis Healthcare’s derivatives, coupled with a significant price decline, highlights a shift towards bearish market positioning. While the stock’s recent technical and volume patterns suggest selling pressure, the upgrade to a 'Hold' rating and mid-cap valuation imply that investors should remain vigilant but not necessarily exit positions immediately.

Careful monitoring of sector trends, broader market cues, and derivatives activity will be essential to gauge Fortis Healthcare’s near-term trajectory. For now, the stock remains a watchlist candidate rather than a clear buy or sell, with better alternatives potentially available across sectors and market caps.

Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →